RUNX3 and asthma: MiR-371 has been confirmed to have the ability to inhibit Runt-related transcription factor 3 (Runx3), a transcription factor that promotes Th1 differentiation, by combining the other four miRNAs, thereby modulating the Th1/Th2 balance in asthma (Qiu et al., 2017).